Results 1 to 10 of about 49,518 (171)
Investigating genetic profiles of cases of Schistosoma spp. imported into Europe: a cohort from the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clinical Parasitology [PDF]
Parasites & VectorsBackground The potential of schistosomiasis to spread across borders, coupled with the considerable delay by which infected travellers and migrants are diagnosed in Europe, calls for better surveillance of the distribution of this disease.
Elena Pomari +26 more
doaj +2 more sources
Frontiers in Molecular Biosciences, 2023 Schistosomes can survive in mammalian hosts for many years, and this is facilitated by released parasite products that modulate the host’s immune system.
Marije E. Kuipers +9 more
doaj +1 more source
Focal eosinophilic infiltration of the liver, benign or malignant?
Clinical Case Reports, 2021 Focal eosinophilic infiltration (FEI) of the liver shares imaging characteristics with malignant hepatic lesions but should be suspected when concomitantly observing eosinophilia. While in itself benign, the cause of FEI should be sought and treated.
Wouter Claeys +7 more
doaj +1 more source
Functional Annotation of Some Hypothetical Genes in the Schistosoma Parasite Based on Reciprocal Best Structural-hit Relationship [PDF]
Research in Molecular Medicine, 2022 Background: The Schistosoma parasite is responsible for several overlooked tropical diseases, which cause significant economic losses in livestock. This parasite is increasingly found in the central areas of the northern provinces of Iran. To generate an
Arezou Askari Rad +3 more
doaj
Frontiers in Immunology, 2023 Schistosomes are long-lived parasitic worms that infect >200 million people globally. The intravascular life stages are known to display acetylcholinesterase (AChE) activity internally as well as, somewhat surprisingly, on external tegumental ...
Patrick J. Skelly, Akram A. Da’dara
doaj +1 more source
Schistosome Vaccine Adjuvants in Preclinical and Clinical Research
Vaccines, 2014 There is currently no vaccine available for human use for any parasitic infections, including the helminth disease, schistosomiasis. Despite many researchers working towards this goal, one of the focuses has been on identifying new antigenic targets. The
Rachel Stephenson +3 more
doaj +1 more source
Schistosomiasis and liver disease: Learning from the past to understand the present
Clinical Case Reports, 2020 To diagnose schistosomiasis, past medical history review should include recent travel to or from an endemic area, a history of elevated liver enzymes as well as contact with contaminated sources of water or farm animals.
Eman Abdelghani +3 more
doaj +1 more source
Frontiers in Immunology, 2019 Parasite-derived lipids may play important roles in host-pathogen interactions and immune evasion mechanisms. Remarkable accumulation of eosinophils is a characteristic feature of inflammation associated with parasitic disease, especially caused by ...
Kelly G. Magalhães +11 more
doaj +1 more source
The essential schistosome tegumental ectoenzyme SmNPP5 can block NAD-induced T cell apoptosis
Virulence, 2020 Infection with intravascular platyhelminths of the genus Schistosoma can result in the debilitating disease schistosomiasis. Schistosomes (blood flukes) can survive in the host for many years.
Catherine S. Nation +2 more
doaj +1 more source
Frontiers in Immunology, 2020 In areas where human schistosomiasis is endemic, infection prevalence and egg output are known to rise rapidly through childhood, reach a peak at 8–15 years of age, and decline thereafter.
Julia C. Buck +4 more
doaj +1 more source